About

Director since March 2019. CEO of ORIC Pharmaceuticals since May 2018; former CFO of Ignyta and investor at TPG Capital. Chairman of the board of Bright Peak Therapeutics.

Roles

4D Molecular Therapeutics, Inc.
Director · Current role
2019–present

Director Compensation

FY 2025
Fees earned or paid in cash
$65,000
Option awards
$70,000
Total
$135,000

Also at 4D Molecular Therapeutics, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.